These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 22996295)

  • 21. Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML).
    Schneider F; Hoster E; Schneider S; Dufour A; Benthaus T; Kakadia PM; Bohlander SK; Braess J; Heinecke A; Sauerland MC; Berdel WE; Buechner T; Woermann BJ; Feuring-Buske M; Buske C; Creutzig U; Thiede C; Zwaan MC; van den Heuvel-Eibrink MM; Reinhardt D; Hiddemann W; Spiekermann K
    Ann Hematol; 2012 Jan; 91(1):9-18. PubMed ID: 21744003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Detection of point mutation at second tyrosine kinase domain of FLT3 gene in acute myeloid leukemia].
    Wang LH; Wang M; Zhou CL; Chen S; Zhang XW; Xing HY; Wang JX
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jun; 26(6):335-8. PubMed ID: 16185475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnosis and prognosis in acute myeloid leukemia--the art of distinction.
    Löwenberg B
    N Engl J Med; 2008 May; 358(18):1960-2. PubMed ID: 18450608
    [No Abstract]   [Full Text] [Related]  

  • 24. [Acute myeloid leukemia].
    Watanabe R
    Rinsho Ketsueki; 2009 Mar; 50(3):154-9. PubMed ID: 19352081
    [No Abstract]   [Full Text] [Related]  

  • 25. Next-generation sequencing for minimal residual disease monitoring in acute myeloid leukemia patients with FLT3-ITD or NPM1 mutations.
    Thol F; Kölking B; Damm F; Reinhardt K; Klusmann JH; Reinhardt D; von Neuhoff N; Brugman MH; Schlegelberger B; Suerbaum S; Krauter J; Ganser A; Heuser M
    Genes Chromosomes Cancer; 2012 Jul; 51(7):689-95. PubMed ID: 22454318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparing apples and oranges in normal karyotype acute myeloid leukemia.
    Medeiros BC
    J Clin Oncol; 2009 Jan; 27(3):474; author reply 474-6. PubMed ID: 19075259
    [No Abstract]   [Full Text] [Related]  

  • 27. KIT and FLT3 receptor tyrosine kinase mutations in acute myeloid leukemia with favorable cytogenetics: two novel mutations and selective occurrence in leukemia subtypes and age groups.
    Sritana N; Auewarakul CU
    Exp Mol Pathol; 2008 Dec; 85(3):227-31. PubMed ID: 18977345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FLT3-TKD mutation in childhood acute myeloid leukemia.
    Liang DC; Shih LY; Hung IJ; Yang CP; Chen SH; Jaing TH; Liu HC; Wang LY; Chang WH
    Leukemia; 2003 May; 17(5):883-6. PubMed ID: 12750701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BRAF mutations in acute leukemias.
    Lee JW; Soung YH; Park WS; Kim SY; Nam SW; Min WS; Lee JY; Yoo NJ; Lee SH
    Leukemia; 2004 Jan; 18(1):170-2. PubMed ID: 14603338
    [No Abstract]   [Full Text] [Related]  

  • 30. Diversity of the juxtamembrane and TKD1 mutations (exons 13-15) in the FLT3 gene with regards to mutant load, sequence, length, localization, and correlation with biological data.
    Schnittger S; Bacher U; Haferlach C; Alpermann T; Kern W; Haferlach T
    Genes Chromosomes Cancer; 2012 Oct; 51(10):910-24. PubMed ID: 22674490
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutual exclusion of ASXL1 and NPM1 mutations in a series of acute myeloid leukemias.
    Carbuccia N; Trouplin V; Gelsi-Boyer V; Murati A; Rocquain J; Adélaïde J; Olschwang S; Xerri L; Vey N; Chaffanet M; Birnbaum D; Mozziconacci MJ
    Leukemia; 2010 Feb; 24(2):469-73. PubMed ID: 19865112
    [No Abstract]   [Full Text] [Related]  

  • 32. Acute myeloid leukemia with myelodysplasia-related changes are characterized by a specific molecular pattern with high frequency of ASXL1 mutations.
    Devillier R; Gelsi-Boyer V; Brecqueville M; Carbuccia N; Murati A; Vey N; Birnbaum D; Mozziconacci MJ
    Am J Hematol; 2012 Jul; 87(7):659-62. PubMed ID: 22535592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Analysis of tyrosine kinases gene mutations in core binding factor related acute myeloid leukemia and its clinical significance].
    Qiao M; Li WY; Sun AN; Chen SN; Liang JY; Ding ZX; Feng YF; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2011 Oct; 32(10):679-83. PubMed ID: 22339826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene expression profiling in AML with normal karyotype can predict mutations for molecular markers and allows novel insights into perturbed biological pathways.
    Kohlmann A; Bullinger L; Thiede C; Schaich M; Schnittger S; Döhner K; Dugas M; Klein HU; Döhner H; Ehninger G; Haferlach T
    Leukemia; 2010 Jun; 24(6):1216-20. PubMed ID: 20428199
    [No Abstract]   [Full Text] [Related]  

  • 35. Prognostic significance and detection of the internal tandem duplication of the FLT3 gene in acute myeloid leukemia.
    Gagyi E; Horváth E; Bödör C; Timár B; Matolcsy A; Pávai Z
    Rom J Morphol Embryol; 2006; 47(4):331-7. PubMed ID: 17392978
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical implications of non-A-type NPM1 and FLT3 mutations in patients with normal karyotype acute myeloid leukemia.
    Park BG; Chi HS; Park SJ; Min SK; Jang S; Park CJ; Kim DY; Lee JH; Lee JH; Lee KH
    Acta Haematol; 2012; 127(2):63-71. PubMed ID: 22104247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Establishment of a rapid and easy method for simultaneous detection of FLT3-ITD and NPM1 gene mutations in acute myeloid leukemia].
    Lu Y; Wang Q; Mu QT; Yu MX; Huang Q; Jin J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Apr; 29(2):163-6. PubMed ID: 22487825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FLT3 and NPM1 mutations in a cohort of AML patients and detection of a novel mutation in tyrosine kinase domain of FLT3 gene from Western India.
    Ghosh K; Swaminathan S; Madkaikar M; Gupta M; Kerketta L; Vundinti B
    Ann Hematol; 2012 Nov; 91(11):1703-12. PubMed ID: 22733614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid detection of FLT3 exon 20 tyrosine kinase domain mutations in patients with acute myeloid leukemia by high-resolution melting analysis.
    Tan AY; Wong SQ; Nyvold CG; Carney DA; Wei A; Seymour JF; Hokland P; Westerman ; Dobrovic A
    Leuk Lymphoma; 2012 Jun; 53(6):1225-9. PubMed ID: 22132874
    [No Abstract]   [Full Text] [Related]  

  • 40. Genomic, immunophenotypic, and NPM1/FLT3 mutational studies on 17 patients with normal karyotype acute myeloid leukemia (AML) followed by aberrant karyotype AML at relapse.
    Wang ES; Sait SN; Gold D; Mashtare T; Starostik P; Ford LA; Wetzler M; Nowak NJ; Deeb G
    Cancer Genet Cytogenet; 2010 Oct; 202(2):101-7. PubMed ID: 20875872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.